During the past decade, Palmetto Health USC Medical Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Palmetto Health USC Medical Group" are "Lumbar Spinal Stenosis" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Palmetto Health USC Medical Group" in a lesser frequency.

Most popular intervention types in "Palmetto Health USC Medical Group" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "MILD" (1 trials) and "Tack Endovascular System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Palmetto Health USC Medical Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Palmetto Health USC Medical Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Palmetto Health USC Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Palmetto Health USC Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".